Sunshine Heart’s David Rosa: “Patients Don’t Like Being Tethered to a Device”

May 1, 2012
“In the U.S., for Class III heart failure there are about 1.5 million patients,” Sunshine Heart CEO David Rosa said. “That’s about 7 times the Class IV market, which is traditionally where LVADs participate.”
Mass Device